This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
SOUTH SAN FRANCISCO, Calif., March 11, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Adam R. Craig, M.D., Ph.D., Executive Vice President, Development and Chief Medical Officer of Sunesis, will be presenting at the 25th Annual Roth Conference on Tuesday, March 19, 2013 at 11:00 AM Pacific Time at The Ritz Carlton in Dana Point, CA.
A live webcast of the presentation will be available on the Sunesis website at
http://ir.sunesis.com . A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.
For additional information on Sunesis, please visit
The Sunesis Pharmaceuticals, Inc. logo is available at
CONTACT: Investor and Media Inquiries:
Sunesis Pharmaceuticals Inc.